[1]
L. Zhou i L. Peng, „Variations and Implications of Irisin, FGF-23, and N-MID Osteocalcin in Diabetic Osteoporosis Patients Undergoing Acarbose Plus Sitagliptin Therapy: A Prospective Cohort Analysis“, J Med Biochem, vol 45, izd. 3, str. 529–538, Sep. 2025, doi: 10.5937/jomb0-60451.